Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

PhRMA has tried to distance its R&D-based members from opportunistic firms like Valeant and Martin ... calling for an end to tax credits for pharmaceutical advertising, and also suggests curbs ...

The first instalment of two-part article looking at people behind the most important events and trends in pharma, biotech and wider world of healthcare in 2015. The year saw a flurry of innovative ...

By David Gelles Valeant Pharmaceuticals is planning to team up with William Ackman in hopes that an increased offer will be enough to end a bidding war for Salix Pharmaceuticals. The company is ...

A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...

Vanda said it will continue to pursue approval of tradipitant in gastroparesis, a condition that affects the stomach muscles and prevents proper stomach emptying, and that it plans to file a separate ...

Key driver of the global onychomycosis market is the increasing prevalence of risk factors such as diabetes, aging population, weakened immune systems, and nail trauma.Westford, USA, Sept. 18, 2024 ...

offering a comprehensive range of pharmaceutical products and services in India and overseas. The company’s core business is focused on providing end-to-end product development and manufacturing ...

The global skincare devices market size was US$ 9 billion in 2019. The global skincare device market is forecast to reach US$ 28 billion by 2030 by growing at a compound annual growth rate (CAGR) of ...